...
首页> 外文期刊>The journal of obstetrics and gynaecology research >Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma
【24h】

Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma

机译:乳酸脱氢酶,D-二聚体和C-反应蛋白对子宫平滑肌的组合血清测定的诊断价值

获取原文
获取原文并翻译 | 示例
           

摘要

Aim Leiomyosarcoma is the most common type of uterine sarcoma. In some leiomyosarcoma cases, preoperative diagnosis might be difficult, and they might be treated as benign lesions. We evaluated diagnostic values of preoperative serum lactate dehydrogenase (LDH), D-dimer and C-reactive protein for differentiating leiomyosarcoma. Methods From 2008 to 2013, leiomyosarcoma cases in three university hospitals were enrolled. Preoperative serum LDH, D-dimer and C-reactive protein were analyzed if tested. These markers of pathologically diagnosed leiomyoma cases presumed benign (group B) and presumed malignant (group PM) were compared with those of leiomyosarcoma cases (group S). Results Groups S, PM and B had 36, 28 and 69 cases, respectively. Positive rates of LDH were 66.7%, 14.3% and 0% in groups S, PM and B, respectively. Positive rates of D-dimer and C-reactive protein were 83.3% and 64.5%, 17.9% and 10.7% and 5% and 2.9% in groups S, PM and B, respectively. Positive rates of all three markers were high in the order of leiomyosarcoma, atypical leiomyoma and typical leiomyoma. In group PM, 12 (63.2%) cases were negative for all three markers, whereas 1 (3.3%) case was negative in group S. No case was positive for all markers in group PM, whereas 41.2% leiomyosarcoma cases were positive for all markers. When all parameters were positive, specificity and positive predictive value were 100% in differentiating leiomyosarcoma from group PM. Conclusion Combination of LDH, D-dimer and C-reactive protein could be useful for distinguishing leiomyosarcoma from especially degenerated or atypical leiomyoma.
机译:目的Leiomyosarcoma是最常见的子宫肉瘤类型。在一些平滑肌肉瘤病例中,术前诊断可能是困难的,并且它们可能被视为良性病变。我们评估了术前血清乳酸脱氢酶(LDH),D-二聚体和C-反应蛋白的诊断值,用于区分平滑肌瘤。方法从2008年到2013年,三所大学医院的Leiomyosarcoma病例都注册。如果测试,分析了术前血清LDH,D-二聚体和C-反应蛋白。将这些病理诊断的平滑肌瘤病例假定良性(B组)和假定恶性(PM PM)的标志物与Leiomyosarcoma病例(组)进行比较。结果分别为36,28和69例。 S的LDH的阳性率分别为组,PM和B组的66.7%,14.3%和0%。 D-二聚体和C反应蛋白的阳性率分别为83.3%和64.5%,17.9%和10.7%,分别为组,PM和B组的5%和2.9%。所有三个标记的阳性率为Leiomyosarcoma,非典型平滑肌瘤和典型的平滑肌瘤的顺序高。在PM,12种(63.2%)病例对所有三个标记的病例为阴性,而1(3.3%)案例在S组中为阴性阴性阴性为阴性。除了PM组中的所有标记没有阳性,而41.2%的Leiomyosarcoma病例为所有标记。当所有参数为阳性时,从PM组区分Leiomyosarcoma,特异性和阳性预测值为100%。结论LDH,D-二聚体和C-反应蛋白的组合可用于区分Leiomyosarcoma特别退化或非典型平滑肌瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号